Heparin Dodecasaccharide Containing Two Antithrombin-binding Pentasaccharides

Christian Viskov, Stefano Elli, Elena Urso, Davide Gaudesi, Pierre Mourier, Frédéric Herman, Christian Boudier, Benito Casu, Giangiacomo Torri, Marco Guerrini

Journal of Biological Chemistry · 2013 · 42 citations · 24 references

DOIFull text

Open access

Concepts

Abstract

The antithrombin (AT) binding properties of heparin and low molecular weight heparins are strongly associated to the presence of the pentasaccharide sequence AGA*IA (A NAc,6S -GlcUA-A NS,3,6S -I 2S -A NS,6S ). By using the highly chemoselective depolymerization to prepare new ultra low molecular weight heparin and coupling it with the original separation techniques, it was possible to isolate a polysaccharide with a biosynthetically unexpected structure and excellent antithrombotic properties. It consisted of a dodecasaccharide containing an unsaturated uronate unit at the nonreducing end and two contiguous AT-binding sequences separated by a nonsulfated iduronate residue. This novel oligosaccharide was characterized by NMR spectroscopy, and its binding with AT was determined by fluorescence titration, NMR, and LC-MS. The dodecasaccharide displayed a significantly increased anti-FXa activity compared with those of the pentasaccharide, fondaparinux, and low molecular weight heparin enoxaparin. Background: Heparin is a linear sulfated polysaccharide used clinically as an anticoagulant. Results: A heparin dodecasaccharide, containing two contiguous antithrombin-binding sequences, has been described and characterized for the first time. Conclusion: The dodecasaccharide binds antithrombin in two different molecular assemblies enhancing the probability of the binding and the affinity. Significance: The discovery of this dodecasaccharide improves the knowledge of heparin structure.

References

24